CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
出版年份 2021 全文链接
标题
CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
作者
关键词
-
出版物
Cells
Volume 10, Issue 7, Pages 1770
出版商
MDPI AG
发表日期
2021-07-14
DOI
10.3390/cells10071770
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
- (2021) Kyoung Min Kim et al. Diagnostic Pathology
- Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
- (2021) Shuai Peng et al. Oncology Letters
- SIRT6 is a DNA double-strand break sensor
- (2020) Lior Onn et al. eLife
- FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma
- (2020) Usama Khamis Hussein et al. Aging-US
- Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
- (2020) Juan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance
- (2020) Claudio D’Amore et al. CELLULAR ONCOLOGY
- Intracellular localization of CK2α as a prognostic factor in invasive breast carcinomas
- (2020) Miwako Kato Homma et al. CANCER SCIENCE
- Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma
- (2020) Zhongkai Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sirtuins and SIRT6 in Carcinogenesis and in Diet
- (2019) de Céu Teixeira et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
- (2019) Chao Jiang et al. Cancer Management and Research
- The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
- (2018) Hye Jeong Park et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SIRT6 inhibits proliferation and invasion in osteosarcoma cells by targeting N‑cadherin
- (2018) Yi Gao et al. Oncology Letters
- SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
- (2018) Jun Sang Bae et al. Frontiers in Oncology
- Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer
- (2017) Xiaobing Shen et al. Oncotarget
- CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients
- (2016) Jun Sang Bae et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers
- (2016) Maj Rabjerg et al. APMIS
- Inhibition of casein kinase 2 prevents growth of human osteosarcoma
- (2016) Kengo Takahashi et al. ONCOLOGY REPORTS
- Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma
- (2016) Maj Rabjerg et al. Oncotarget
- Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
- (2016) Florian Engert et al. Oncotarget
- Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway
- (2016) Lihong Bai et al. Oncotarget
- Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells
- (2015) Michele Cea et al. BLOOD
- CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients
- (2014) Jun Sang Bae et al. INTERNATIONAL JOURNAL OF CANCER
- MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
- (2014) U. Thirumurthi et al. Science Signaling
- Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients
- (2013) Jens U. Marquardt et al. HEPATOLOGY
- New targets and approaches in osteosarcoma
- (2012) Jonathan Gill et al. PHARMACOLOGY & THERAPEUTICS
- Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes
- (2011) Jinjin Zou et al. Journal of Translational Medicine
- Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer
- (2011) Kai-Yuan Lin et al. PLoS One
- SIRT6 Promotes DNA Repair Under Stress by Activating PARP1
- (2011) Z. Mao et al. SCIENCE
- SIRT6 in DNA repair, metabolism and ageing
- (2010) D. B. Lombard et al. JOURNAL OF INTERNAL MEDICINE
- Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2
- (2009) Barbara Zschoernig et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
- (2009) Maria Ruzzene et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis
- (2008) Giovanni Di Maira et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search